Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...

Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat ...

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...

Mirum Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CTEXLItm (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous ...

When his phone rang at 11.30pm on a winter’s night last year, organ transplant recipient David Wightman knew it could be a ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...

Sterotherapeutics, a leading biopharmaceutical company dedicated to advancing innovative therapies, is announcing the launch of a Phase 2 clinical trial for ST-002, a novel drug candidate for patients ...

PBC是一种罕见的慢性自身免疫性胆管疾病，在女性中更为常见，并会导致肝损伤，若不治疗，可能进展为可致命的肝功能衰竭。PBC最常见的症状为瘙痒和疲劳，目前尚无治愈PBC的方法，治疗目标包括减缓疾病进展以及减轻与胆汁淤积相关的症状，如胆汁性瘙痒。治疗效果 ...

Clinical Study, GlobeNewswire, Pharmaceuticals & Biotechnology, Research Analysis and Reports | HG is a rare, debilitating condition of pregnancy, character ...